Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated

Symptoms, Warnings, and Emergencies

At a Glance

MASH often causes no noticeable symptoms, so feeling well does not prove the disease is mild. Blood-test scores and liver imaging help monitor scarring, while jaundice, severe belly swelling, bleeding, confusion, or severe pain require immediate emergency care.

Metabolic Dysfunction-Associated Steatohepatitis (MASH) is often described as a “silent” disease. For many people, the liver can accumulate fat and become inflamed without causing any outward signs of trouble [1][2].

Because the liver tissue itself has limited pain sensation, you might not feel anything at all as the disease progresses from early to moderate stages. Understanding the difference between vague symptoms and genuine emergencies can help you manage your health without unnecessary panic.

The Silent Stage: Early and Moderate MASH

In the early and moderate stages of MASH, you likely won’t feel “sick” in the traditional sense. Most people are diagnosed through blood tests or imaging done for other reasons, rather than because of a specific symptom [3].

However, some people do report vague, non-specific symptoms. While these don’t happen to everyone, they can include:

  • Fatigue: A general sense of tiredness or lack of energy that doesn’t always improve with rest [4].
  • Right Upper Quadrant Discomfort: A dull ache or a feeling of fullness in the upper right side of your abdomen, where the liver is located. While the liver lacks robust pain receptors, its capsule and nearby structures can produce pain or pressure when stretched.

It is important to remember that these symptoms are common to many health conditions. Feeling tired doesn’t automatically mean your liver health is declining, but it is worth discussing with your care team. Crucially, symptoms should not be used to stage MASH.

The Importance of Monitoring

Because MASH can remain quiet even as it advances, doctors use specialized tools to check on your liver’s health [3]. Rather than waiting for symptoms, your doctor may use:

  • Non-Invasive Tests (NITs): Such as the FIB-4 score, which uses your age and standard blood test results (like your platelet count) to estimate liver health [3].
  • Imaging: Tests like transient elastography (often called a FibroScan) to measure how “stiff” or scarred your liver is [3][5].

The goal of regular monitoring is to identify any changes long before “red flag” symptoms ever appear [6].

Advanced Symptoms: “Red Flags”

Serious symptoms can signal that the liver is struggling to perform its vital functions. These findings commonly signal decompensation in a person with cirrhosis (extensive scarring) [7][8]. However, it is critical to know that these symptoms require urgent medical evaluation regardless of your presumed MASH stage, because they can have causes other than MASH, such as acute liver injury, cardiac disease, infection, or gastrointestinal bleeding. Additionally, a person may not know they have cirrhosis.

When to Seek Urgent Medical Care

If you ever experience any of the following, you should seek emergency medical attention immediately:

Symptom What it Means
Jaundice Yellowing of the eyes or skin, caused by the liver’s inability to process bilirubin [9].
Ascites A sudden, severe swelling or “tightness” of the belly caused by fluid buildup [10].
Hematemesis or Melena Vomiting blood (which may look like coffee grounds) or passing black, tarry stools. This can signal bleeding in the esophagus or stomach (variceal bleeding) [11].
Hepatic Encephalopathy Sudden confusion, extreme sleepiness, or significant changes in personality/behavior caused by toxins building up in the brain [4].
Severe Edema Significant swelling in the legs, ankles, or feet that leaves an indentation when pressed [10].
Fever or Severe Abdominal Pain Especially when combined with ascites, this can signal a serious infection.

These symptoms represent a medical crisis where the liver or another system is struggling to function [12]. For the vast majority of people with early MASH, the journey is about preventing these complications through proactive care and metabolic management.

Common questions in this guide

Can MASH cause symptoms in its early stages?
Often, no. Early and moderate MASH may cause no noticeable symptoms, although some people report fatigue or a dull ache or fullness in the upper right abdomen. These symptoms are nonspecific and do not show how advanced the disease is.
Does having no MASH symptoms mean the disease is mild?
No. MASH can remain quiet while liver inflammation or scarring progresses, so symptoms cannot determine its stage. Clinicians use blood-test calculations such as FIB-4 and imaging such as FibroScan to assess liver health.
What MASH symptoms require emergency medical care?
Get immediate emergency care for yellow skin or eyes, sudden severe belly swelling, vomiting blood, black tarry stools, new confusion or extreme sleepiness, major leg swelling, fever, or severe abdominal pain. These signs may indicate serious liver dysfunction or another urgent problem and should not be assumed to be caused only by MASH.
Is right-sided upper abdominal pain a symptom of MASH?
Some people with MASH notice a dull ache or fullness in the upper right abdomen, but many do not. This symptom has many possible causes and cannot stage MASH, so tell your clinician about persistent or changing discomfort.
How is MASH monitored when symptoms are absent?
Doctors may use routine blood tests to calculate a FIB-4 score and an imaging test called transient elastography, often known as FibroScan. These tests help estimate liver health and stiffness or scarring before serious warning signs appear.
When should I ask about screening for varices or liver cancer?
Ask your clinician about this when discussing liver scarring or cirrhosis, because screening decisions depend on your liver findings and overall risk rather than symptoms alone. Your clinician can tell you which tests are appropriate and when to schedule them.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on metabolic dysfunction-associated steatohepatitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I don't have any major symptoms, does that mean my MASH is definitely in the early stages?
  2. 2.I sometimes feel a dull ache in my upper right side—is this common for my stage of MASH?
  3. 3.What specifically should I watch for that would indicate my liver condition is changing or worsening?
  4. 4.At what point would I need to start screening for complications like varices or liver cancer?
  5. 5.If I experience a sudden increase in fatigue, should I call the office or wait for my next appointment?

References

References (12)
  1. 1

    Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes.

    Alhinai A, Patel K, Fonseca VA, Sebastiani G

    Journal of diabetes and its complications 2021; (35(9)):107978 doi:10.1016/j.jdiacomp.2021.107978.

    PMID: 34183247
  2. 2

    Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review.

    Tilg H, Petta S, Stefan N, Targher G

    JAMA 2026; (335(2)):163-174 doi:10.1001/jama.2025.19615.

    PMID: 41212550
  3. 3

    EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

    , ,

    Journal of hepatology 2024; (81(3)):492-542 doi:10.1016/j.jhep.2024.04.031.

    PMID: 38851997
  4. 4

    Palliative care for patients with end-stage liver disease.

    Larson AM

    Current gastroenterology reports 2015; (17(5)):440 doi:10.1007/s11894-015-0440-6.

    PMID: 25855211
  5. 5

    Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database.

    Luthra R, Sheth A

    Advances in therapy 2025; (42(2)):1165-1195 doi:10.1007/s12325-024-03085-4.

    PMID: 39739194
  6. 6

    EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

    , ,

    Obesity facts 2024; (17(4)):374-444 doi:10.1159/000539371.

    PMID: 38852583
  7. 7

    Acute and non-acute decompensation of liver cirrhosis.

    McCoy MS, Angeli P, Trebicka J

    Liver international : official journal of the International Association for the Study of the Liver 2025; (45(3)):e15861 doi:10.1111/liv.15861.

    PMID: 38426268
  8. 8

    Interaction of inflammation and portal hypertension in cirrhosis progression.

    Costa D, Trebicka J, Ripoll C, et al.

    Nature reviews. Gastroenterology & hepatology 2025; (22(12)):846-865 doi:10.1038/s41575-025-01107-2.

    PMID: 41023416
  9. 9

    Negative impact of the pandemic on hospital admissions, morbidity and early mortality for acute cirrhosis decompensation.

    Gananandan K, Phillips A, Chikhlia A, et al.

    BMJ open gastroenterology 2023; (10(1)) doi:10.1136/bmjgast-2022-001071.

    PMID: 36650007
  10. 10

    Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers.

    Vidal González D, Pérez López KP, Vera Nungaray SA, Moreno Madrigal LG

    Gastroenterologia y hepatologia 2022; (45(9)):715-723 doi:10.1016/j.gastrohep.2022.02.004.

    PMID: 35257809
  11. 11

    Beta-adrenergic blockade in cirrhosis - harmful or helpful?

    Møller S, Danielsen KV, Nabilou P, et al.

    Expert review of gastroenterology & hepatology 2023; (17(6)):519-529 doi:10.1080/17474124.2023.2215428.

    PMID: 37202907
  12. 12

    Management of Decompensated Cirrhosis and Associated Syndromes.

    Chandna S, Zarate ER, Gallegos-Orozco JF

    The Surgical clinics of North America 2022; (102(1)):117-137 doi:10.1016/j.suc.2021.09.005.

    PMID: 34800381

This page is for informational purposes only and does not constitute medical advice. Seek immediate medical care for red-flag symptoms, and ask your clinician how your symptoms and liver-monitoring results apply to you.